Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 10, 2010, Pages 1585-1595

  Shen, Zhengbin ^a   Zhou, Shuang ^a   Wang, Yanna ^a   Li, Ri Lun ^a   Zhong, Cuiping ^a   Liang, Chunmin ^a   Sun, Yihong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Gastric cancer; Lymph nodes; Prognosis; Regulatory T cells

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; STOMACH CANCER; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; T-LYMPHOCYTES, REGULATORY; TISSUE ARRAY ANALYSIS;

EID: 77956064457     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0816-9     Document Type: Article

References (34)

1. T Alvaro M Lejeune MT Salvado, et al. 2005 Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells Clin Cancer Res 11 1467 1473 10.1158/1078-0432.CCR-04-1869 15746048
2. B Amy Heimberger AG Mohamed, et al. 2008 Incidence and prognostic impact of Foxp3+ regulatory T cells in human gliomas Clin Cancer Res 14 5166 5172 10.1158/1078-0432.CCR-08-0320
3. C Badoual S Hans J Rodriguez, et al. 2006 Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers Clin Cancer Res 12 465 472 10.1158/1078-0432.CCR-05-1886 1:CAS:528: DC%2BD28XmtlKitg%3D%3D 16428488
4. GJ Bates SB Fox C Han, et al. 2006 Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse J Clin Oncol 24 5373 5380 10.1200/JCO.2006.05.9584 17135638
5. SH Chiou BC Sheu WC Chang, et al. 2005 Current concepts of tumor-infiltrating lymphocytes in human malignancies J Reprod Immunol 67 35 50 10.1016/j.jri.2005.06.002 1:CAS:528:DC%2BD2MXhtVynt7rK 16111767
6. TJ Curiel G Coukos L Zou, et al. 2004 Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 942 949 10.1038/nm1093 1:CAS:528:DC%2BD2cXntFSkt7g%3D 15322536
7. D Dieckmann CH Bruett H Ploettner MB Lutz G Schuler 2002 Human CD41CD251 regulatory, contact-dependent T cells, induce interleukin 10-producing, contact-independent type 1-like regulatory T cells J Exp Med 196 247 253 10.1084/jem.20020642 1:CAS:528:DC%2BD38XlsV2ms7g%3D 12119349
8. KE Earle Q Tang X Zhou W Liu S Zhu ML Bonyhadi JA Bluestone 2005 In vitro expanded human CD41CD251 regulatory T cells suppress effector T cell proliferation Clin Immunol 115 3 9 10.1016/j.clim.2005.02.017 1:CAS:528:DC%2BD2MXkslyqtbY%3D 15870014
9. J Fu D Xu Z Liu, et al. 2007 Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients Gastroenterology 132 2328 2339 10.1053/j.gastro.2007.03.102 17570208
10. J Galon A Costes F Sanchez-Cabo, et al. 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 1960 1964 10.1126/science.1129139 1:CAS:528:DC%2BD28XhtVSnsrnK 17008531
11. Q Gao SJ Qiu J Fan, et al. 2007 Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection J Clin Oncol 25 2586 2593 10.1200/JCO.2006.09.4565 17577038
12. P Giuseppe AR Pier C Vincenzo, et al. 2008 Intratumoural Foxp3+ Regulatory T cells are associated with adverse prognosis in radically resected gastric cancer Eur J Cancer 44 1875 1882 10.1016/j.ejca.2008.05.017
13. GG Grabenbauer G Lahmer L Distel, et al. 2006 Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma Clin Cancer Res 12 3355 3360 10.1158/1078-0432.CCR-05-2434 1:CAS:528:DC%2BD28XltFyis74%3D 16740757
14. RW Griffiths E Elkord DE Gilham, et al. 2007 Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival Cancer Immunol Immunother 56 1743 1753 10.1007/s00262-007-0318-z 17487490
15. N Hiraoka K Onozato T Kosuge S Hirohashi 2006 Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions Clin Cancer Res 12 5423 5434 10.1158/1078-0432.CCR-06-0369 1:CAS:528:DC%2BD28XpvFShsLc%3D 17000676
16. S Hori S Sakaguchi 2004 Foxp3: a critical regulator of the development and function of regulatory T cells Microbes Infect 6 745 751 10.1016/j.micinf.2004.02.020 1:CAS:528:DC%2BD2cXltVOgur8%3D 15207821
17. F Ichihara K Kono A Takahashi H Kawaida, et al. 2003 Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patient with gastric and esophageal cancers Clin Cancer Res 9 4404 4408 14555512
18. Japanese Gastric Cancer Association 1998 Japanese classification of gastric carcinoma-2nd English edition Gastric Cancer 1 10 24 10.1007/PL00011681 11957040
19. F Kamangar GM Dores WF Anderson 2006 Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 14 2137 2150 10.1200/JCO.2005.05.2308 16682732
20. high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer J Surg Res 124 151 157 10.1016/j.jss.2004.10.004 1:CAS:528:DC%2BD2MXhslWrsbc%3D 15734494
21. J Kononen L Bubendorf A Kallioniemi, et al. 1998 Tissue microarrays for high throughput molecular profiling of tumor specimens Nat Med 4 844 847 10.1038/nm0798-844 1:CAS:528:DyaK1cXktlKntr8%3D 9662379
22. AM Lee AJ Clear M Calaminici, et al. 2006 Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome J Clin Oncol 24 5052 5059 10.1200/JCO.2006.06.4642 1:CAS:528:DC%2BD28Xht1Gnur3N 17033038
23. JF Li YW Chu GM Wang, et al. 2008 The prognostic value of peritumoral regulatory T cells and its correction with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma BJU Int 103 399 405 10.1111/j.1464-410X.2008.08151.x 19021626
24. MS Longhi MJ Hussain RR Mitry, et al. 2006 Functional study of CD41CD251 regulatory T cells in health and autoimmune hepatitis J Immunol 176 4484 4491 1:CAS:528:DC%2BD28Xis1eqsb4%3D 16547287
25. Y Mizukami K Kono Y Kawaguchi, et al. 2008 Localisation pattern of Foxp3+ regulatory T cell is associated with clinical behavior in gastric cancer Br J Cancer 98 148 153 10.1038/sj.bjc.6604149 1:CAS:528:DC%2BD1cXisF2rsg%3D%3D 18087278
26. O Nakano M Sato Y Naito, et al. 2001 Proliferative activity of intratumoral CD8+ T-lymphocytes as a prognostic factor in human renal cell carcinoma: Clinicopathologic demonstration of antitumor immunity Cancer Res 61 5132 5136 1:CAS:528:DC%2BD3MXltVequ7Y%3D 11431351
27. RP Petersen MJ Campa J Sperlazza, et al. 2006 Tumor-infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients Cancer 107 2866 2872 10.1002/cncr.22282 17099880
28. CA Piccirillo AM Thornton 2004 Cornerstone of peripheral tolerance: naturally occurring CD4+ CD25+ regulatory T cells Trends Immunol 25 374 380 10.1016/j.it.2004.04.009 1:CAS:528:DC%2BD2cXltVKjtb8%3D 15207505
29. P Salama M Phillips F Grieu, et al. 2008 Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer J Clin Oncol 27 186 192 10.1200/JCO.2008.18.7229 19064967
30. E Sato SH Olson J Ahn, et al. 2005 Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci USA 102 18538 18543 10.1073/pnas.0509182102 1:CAS:528:DC%2BD28Xpt1Om 16344461
31. K Schumacher W Haensch C Roefzaad, et al. 2001 Prognostic significance of activated CD8+ T cell infiltrations within esophageal carcinomas Cancer Res 61 3932 3936 1:CAS:528:DC%2BD3MXktVWqsLo%3D 11358808
32. P Yu YX Fu 2006 Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 86 231 245 10.1038/labinvest.3700389 1:CAS:528:DC%2BD28XhsFSmurk%3D 16446705
33. Yuan XL, Chen L, Li MX et al (2009) Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2- dependent manner. Clin Immunol. 7 Nov 2009 [Epub ahead of print]
34. W Zou 2006 Regulatory T cells, tumor immunity and immunotherapy Nat Rev Immunol 6 295 307 10.1038/nri1806 1:CAS:528:DC%2BD28XivVyru7k%3D 16557261